Sanofi SA said on Monday the US Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.
Maintaining a compound annual growth rate (CAGR) of over 20 per cent, wellness firm Himalaya Drug Company is looking at a revenue of Rs 2,500 crore next fiscal year and plans to hire around 1,000 people as it enters new verticals and expands distribution network.
The Competition Commission of India (CCI) has approved Ajay Piramal-led Piramal Enterprises' proposed acquisition of four brands from pharmaceutical major Pfizer.
Thirteen leading drug makers promised on Tuesday to clean up pollution from factories making antibiotics and take steps to curb overuse of the medicines as part of a drive to fight the rise of drug-resistant superbugs.
Sharon Bio-Medicine on Tuesday said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra.
Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US generic Paricalcitol injection used for treatment associated with chronic kidney disease.
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
Government has slashed prices of 10 more drugs while bringing eight new medicines, including paracetamol, under price control for the first time in its bid to cap cost of over 800 plus formulations to make them affordable.
Drug firm Natco Pharma is aiming to file over 10 Abbreviated New Drug Applications (ANDAs) in the US in the next two financial years to expand its presence in the American market.
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
Dr Reddy's Laboratories (DRL) has expanded its strategic collaboration with US-based independent biotechnology firm Amgen to market and distribute in India three of latter's medicines, used in the therapy areas of oncology and osteoporosis.
Zydus Cadila is recalling over 14,800 bottles of Bromocriptine Mesylate capsules manufactured by Cadila Healthcare on account of out of specification results.
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesion.
US Department of Justice has sent summons to Sun Pharmaceutical Industries' US arm Taro Pharmaceutical Industries Inc and its two senior executives seeking information on generic drug pricing. has sent summons to Sun Pharmaceutical Industries' US arm Taro Pharmaceutical Industries Inc and its two senior executives seeking information on generic drug pricing.
Drug firm Suven Life Sciences has been granted a patent each by Canada, Europe and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
Drug firm Lupin has received tentative approval from the US health regulator to market its generic anti-bacterial moxifloxacin hydrochloride tablets in the American market.
The company has launched the drug in strengths of 100 mg, 150 mg and 200 mg, Dr Reddy's Laboratories said in a regulatory filing.